BancFirst Trust & Investment Management’s Pfizer PFE Stock Holding History

BancFirst Trust & Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,978	Closed	-$475K	–	54
2024 Q4	$475K	Sell	17,978 -93	-0.5%	-$2.52K	0.21%	32
2024 Q3	$526K	Sell	18,071 -217	-1%	-$6.33K	0.18%	28
2024 Q2	$508K	Buy	18,288 +494	+3%	+$13.6K	0.24%	27
2024 Q1	$494K	Hold	17,794	–	–	0.23%	24
2023 Q4	$512K	Hold	17,794	–	–	0.23%	24
2023 Q3	$571K	Hold	17,794	–	–	0.28%	20
2023 Q2	$643K	Hold	17,794	–	–	0.37%	13
2023 Q1	$719K	Buy	17,794 +398	+2%	+$17.2K	0.43%	16
2022 Q4	$893K	Hold	17,396	–	–	0.51%	15
2022 Q3	$768K	Sell	17,396 -814	-4%	-$39.6K	0.46%	16
2022 Q2	$1.07M	Sell	18,210 -1,201	-6%	-$61.2K	0.83%	11
2022 Q1	$1M	Buy	19,411 +1,201	+7%	+$62.3K	0.64%	12
2021 Q4	$1.07M	Buy	+18,210	New	+$902K	0.83%	11

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BancFirst Trust & Investment Management's PFE Position: Q1 2025 in Review

BancFirst Trust & Investment Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 17,978 shares — an estimated $475K sold.

BancFirst Trust & Investment Management first reported a position in PFE in Q4 2021 and held it in 13 quarters. The position peaked at $1.07M in Q2 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

BancFirst Trust & Investment Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
BancFirst Trust & Investment Management sold 17,978 Pfizer shares in Q1 2025, an estimated $475K.
BancFirst Trust & Investment Management first reported a position in Pfizer in Q4 2021 and held it in 13 quarters.
BancFirst Trust & Investment Management's Pfizer position peaked at $1.07M in Q2 2022.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on BancFirst Trust & Investment Management's 13F filing for Q1 2025, filed 15 Apr 2025.